Immunoglobulin replacement products in current clinical use in the United States have poor neutralizing activity against SARS-CoV-2 Omicron strains
Alexa Doss, Chieh-Yu Liang, Jennifer Monroy, James Wedner, Christopher J. Rigell, Hannah G. Davis-Adams, Lucas J. Adams, Peggy L. Kendall, Michael Diamond, Ofer Zimmerman
Clinical Immunology, 2023
Abstract
An abstract is not available for this record. Please visit the publisher website for more details.